Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 66

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors

van Iersel, Laura, Mulder, Renee L, Denzer, Christian, Cohen, Laurie E, Spoudeas, Helen A, Meacham, Lillian R, Sugden, Elaine, Schouten-van Meeteren, Antoinette Y N, Hoving, Eelco W, Packer, Roger J, Armstrong, Gregory T, Mostoufi-Moab, Sogol, Stades, Aline M, van Vuurden, Dannis, Janssens, Geert O, Thomas-Teinturier, Cécile, Murray, Robert D, Di Iorgi, Natascia, Neggers, Sebastian J C M M, Thompson, Joel, Toogood, Andrew A, Gleeson, Helena, Follin, Cecilia, Bardi, Edit, Torno, Lilibeth, Patterson, Briana, Morsellino, Vera, Sommer, Grit, Clement, Sarah C, Srivastava, Deokumar, Kiserud, Cecilie E, Fernandez, Alberto, Scheinemann, Katrin, Raman, Sripriya, Yuen, Kevin C J, Wallace, W Hamish, Constine, Louis S, Skinner, Roderick, Hudson, Melissa M, Kremer, Leontien C M, Chemaitilly, Wassim, van Santen, Hanneke M·2022·Endocrine Reviews
DOI 10.1210/endrev/bnab040
Open this paper in CoChat — free account

Abstract

Endocrine disorders in survivors of childhood, adolescent, and young adult (CAYA) cancers are associated with substantial adverse physical and psychosocial effects. To improve appropriate and timely endocrine screening and referral to a specialist, the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) aims to develop evidence and expert consensus-based guidelines for healthcare providers that harmonize recommendations for surveillance of endocrine disorders in CAYA cancer survivors. Existing IGHG surveillance recommendations for premature ovarian insufficiency, gonadotoxicity in males, fertility preservation, and thyroid cancer are summarized. For hypothalamic-pituitary (HP) dysfunction, new surveillance recommendations were formulated by a guideline panel consisting of 42 interdisciplinary international experts. A systematic literature search was performed in MEDLINE (through PubMed) for clinically relevant questions concerning HP dysfunction. Literature was screened for eligibility. Recommendations were formulated by drawing conclusions from quality assessment of all evidence, considering the potential benefits of early detection and appropriate management. Healthcare providers should be aware that CAYA cancer survivors have an increased risk for endocrine disorders, including HP dysfunction. Regular surveillance with clinical history, anthropomorphic measures, physical examination, and laboratory measurements is recommended in at-risk survivors. When endocrine disorders are suspected, healthcare providers should proceed with timely referrals to specialized services. These international evidence-based recommendations for surveillance of endocrine disorders in CAYA cancer survivors inform healthcare providers and highlight the need for long-term endocrine follow-up care in subgroups of survivors and elucidate opportunities for further research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/endrev/bnab040

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 81

  1. Gatta, 2009, Survival of European children and young adults with cancer diagnosed 1995-2002, Eur J Cancer., 45, 992, 10.1016/j.ejca.2008.11.042 · DOI · Paper page
  2. Howlader, 2016, SEER Cancer Statistics Review, 1975–2013.
  3. Robison, 2014, Survivors of childhood and adolescent cancer: life-long risks and responsibilities, Nat Rev Cancer., 14, 61, 10.1038/nrc3634 · DOI · Paper page
  4. Mostoufi-Moab, 2016, Endocrine abnormalities in aging survivors of childhood cancer: a report from the Childhood Cancer Survivor study, J Clin Oncol., 34, 3240, 10.1200/JCO.2016.66.6545 · DOI
  5. van Iersel, 2019, Hypothalamic-pituitary disorders in childhood cancer survivors: prevalence, risk factors and long-term health outcomes, J Clin Endocrinol Metab., 104, 6101, 10.1210/jc.2019-00834 · DOI
  6. Clement, 2016, Prevalence and risk factors of early endocrine disorders in childhood brain tumor survivors: a nationwide, multicenter study, J Clin Oncol., 34, 4362, 10.1200/JCO.2016.67.5025 · DOI
  7. Chemaitilly, 2019, Childhood cancer treatments and associated endocrine late effects: a concise guide for the pediatric endocrinologist, Horm Res Paediatr., 91, 74, 10.1159/000493943 · DOI
  8. Chemaitilly, 2015, Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study, J Clin Oncol., 33, 492, 10.1200/JCO.2014.56.7933 · DOI · Paper page
  9. van Iersel, 2020, Clinical impact of hypothalamic-pituitary disorders after conformal radiation therapy for pediatric low-grade glioma or ependymoma, Pediatr Blood Cancer., 67, e28723, 10.1002/pbc.28723 · DOI
  10. Pradhan, 2019, Endocrine and metabolic disorders in survivors of childhood cancers and health-related quality of life and physical activity, J Clin Endocrinol Metab., 104, 5183, 10.1210/jc.2019-00627 · DOI
  11. Kremer, 2013, A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group, Pediatr Blood Cancer., 60, 543, 10.1002/pbc.24445 · DOI · Paper page
  12. Skinner, 2017, Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium, Lancet Oncol., 18, e75, 10.1016/S1470-2045(17)30026-8 · DOI
  13. Clement, 2018, Balancing the benefits and harms of thyroid cancer surveillance in survivors of childhood, adolescent and young adult cancer: recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium, Cancer Treat Rev., 63, 28, 10.1016/j.ctrv.2017.11.005 · DOI
  14. van Dorp, 2016, Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration with the PanCareSurFup Consortium, J Clin Oncol., 34, 3440, 10.1200/JCO.2015.64.3288 · DOI
  15. Mulder, 2021, Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group, Lancet Oncol., 22, e45, 10.1016/S1470-2045(20)30594-5 · DOI
  16. Mulder, 2021, Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group, Lancet Oncol., 22, e57, 10.1016/S1470-2045(20)30582-9 · DOI
  17. Chemaitilly, 2017, Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude Lifetime cohort, J Clin Endocrinol Metab., 102, 2242, 10.1210/jc.2016-3723 · DOI
  18. Anderson, 2015, Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults, Lancet Diabetes Endocrinol., 3, 556, 10.1016/S2213-8587(15)00039-X · DOI · Paper page
  19. De Vos, 2010, Primary ovarian insufficiency, Lancet., 376, 911, 10.1016/S0140-6736(10)60355-8 · DOI · Paper page
  20. Medica, 2021, Beyond premature ovarian insufficiency: staging reproductive aging in adolescent and young adult cancer survivors, J Clin Endocrinol Metab., 106, e1002, 10.1210/clinem/dgaa797 · doi:10.1210/clinem/dgaa797
  21. van Iersel, 2018, Erectile dysfunction in male survivors of childhood cancer, JAMA Oncol., 4, 1613, 10.1001/jamaoncol.2018.4420 · DOI
  22. Ritenour, 2016, Erectile dysfunction in male survivors of childhood cancer: a report from the Childhood Cancer Survivor study, J Sex Med., 13, 945, 10.1016/j.jsxm.2016.03.367 · DOI
  23. Reulen, 2011, Long-term risks of subsequent primary neoplasms among survivors of childhood cancer, JAMA., 305, 2311, 10.1001/jama.2011.747 · DOI · Paper page
  24. Armstrong, 2011, Survival and long-term health and cognitive outcomes after low-grade glioma, Neuro Oncol., 13, 223, 10.1093/neuonc/noq178 · DOI
  25. Gleeson, 2003, Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement, J Clin Endocrinol Metab., 88, 3682, 10.1210/jc.2003-030366 · DOI
  26. Guyatt, 2011, GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables, J Clin Epidemiol., 64, 383, 10.1016/j.jclinepi.2010.04.026 · DOI · Paper page
  27. Atkins, 2004, Grading quality of evidence and strength of recommendations, BMJ., 328, 1490, 10.1136/bmj.328.7454.1490 · DOI · Paper page
  28. Gibbons, 2003, American College of Cardiology/American Heart Association clinical practice guidelines: Part II: evolutionary changes in a continuous quality improvement project, Circulation., 107, 3101, 10.1161/01.CIR.0000079017.53579.9C · DOI
  29. Gan, 2015, Neuroendocrine morbidity after pediatric optic gliomas: a longitudinal analysis of 166 children over 30 years, J Clin Endocrinol Metab., 100, 3787, 10.1210/jc.2015-2028 · DOI
  30. Shalitin, 2011, Endocrine outcome in long-term survivors of childhood brain tumors, Horm Res Paediatr., 76, 113, 10.1159/000327584 · DOI
  31. Clayton, 1991, Dose dependency of time of onset of radiation-induced growth hormone deficiency, J Pediatr., 118, 226, 10.1016/S0022-3476(05)80487-1 · DOI
  32. Merchant, 2011, Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors, J Clin Oncol., 29, 4776, 10.1200/JCO.2011.37.9453 · DOI
  33. Schmiegelow, 2000, Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study, Clin Endocrinol (Oxf)., 53, 191, 10.1046/j.1365-2265.2000.01079.x · DOI
  34. Schmiegelow, 2003, Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor, J Clin Endocrinol Metab., 88, 3149, 10.1210/jc.2002-021994 · DOI
  35. Eaton, 2016, Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma, Neuro Oncol., 18, 881, 10.1093/neuonc/nov302 · DOI
  36. Gurney, 2006, Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia, Cancer., 107, 1303, 10.1002/cncr.22120 · DOI · Paper page
  37. Shalitin, 2006, Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence, Bone Marrow Transplant., 37, 1109, 10.1038/sj.bmt.1705374 · DOI
  38. Davis, 2015, Growth hormone deficiency after childhood bone marrow transplantation with total body irradiation: interaction with adiposity and age, Clin Endocrinol (Oxf)., 83, 508, 10.1111/cen.12773 · DOI
  39. Brennan, 1998, Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood, Clin Endocrinol (Oxf)., 48, 777, 10.1046/j.1365-2265.1998.00438.x · DOI · Paper page
  40. Leung, 2007, A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation, Medicine (Baltimore)., 86, 215, 10.1097/MD.0b013e31812f864d · DOI
  41. Brauner, 1990, Growth and endocrine disorders in optic glioma, Eur J Pediatr., 149, 825, 10.1007/BF02072067 · doi:10.1007/bf02072067
  42. Clement, 2016, Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma, Eur J Cancer., 54, 1, 10.1016/j.ejca.2015.10.064 · DOI
  43. Kanev, 1991, Growth hormone deficiency following radiation therapy of primary brain tumors in children, J Neurosurg., 74, 743, 10.3171/jns.1991.74.5.0743 · doi:10.3171/jns.1991.74.5.0743
  44. Laughton, 2008, Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial, J Clin Oncol., 26, 1112, 10.1200/JCO.2008.13.5293 · DOI
  45. Sanders, 2005, Final adult height of patients who received hematopoietic cell transplantation in childhood, Blood., 105, 1348, 10.1182/blood-2004-07-2528 · DOI
  46. Uday, 2015, Endocrine sequelae beyond 10 years in survivors of medulloblastoma, Clin Endocrinol (Oxf)., 83, 663, 10.1111/cen.12815 · DOI
  47. Ramanauskienė, 2014, Early development of endocrine and metabolic consequences after treatment of central nervous system tumors in children, Medicina (Kaunas)., 50, 275, 10.1016/j.medici.2014.10.006 · DOI
  48. Merchant, 2009, Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits, J Clin Oncol., 27, 3691, 10.1200/JCO.2008.21.2738 · DOI · Paper page
  49. Yock, 2016, Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study, Lancet Oncol., 17, 287, 10.1016/S1470-2045(15)00167-9 · DOI · Paper page
  50. Hua, 2012, Predicting the probability of abnormal stimulated growth hormone response in children after radiotherapy for brain tumors, Int J Radiat Oncol Biol Phys., 84, 990, 10.1016/j.ijrobp.2012.01.049 · doi:10.1016/j.ijrobp.2012.01.049
  51. Sklar, 1993, Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation, Acta Endocrinol (Copenh)., 129, 511, 10.1530/acta.0.1290511 · DOI · Paper page
  52. Tillmann, 1998, Serum insulin-like growth factor-I, IGF binding protein-3 and IGFBP-3 protease activity after cranial irradiation, Horm Res., 50, 71
  53. Patterson, 2009, Adrenal function testing in pediatric cancer survivors, Pediatr Blood Cancer., 53, 1302, 10.1002/pbc.22208 · DOI
  54. Bakker, 2007, Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood, Clin Endocrinol (Oxf)., 67, 589, 10.1111/j.1365-2265.2007.02930.x · doi:10.1111/j.1365-2265.2007.02930.x
  55. Brignardello, 2015, GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution, J Endocrinol Invest., 38, 171, 10.1007/s40618-014-0179-1 · DOI
  56. Ergun-Longmire, 2006, Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor, J Clin Endocrinol Metab., 91, 3494, 10.1210/jc.2006-0656 · DOI · Paper page
  57. Leung, 2002, Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia, J Clin Oncol., 20, 2959, 10.1200/JCO.2002.09.142 · DOI
  58. Mackenzie, 2011, Long-term safety of growth hormone replacement after CNS irradiation, J Clin Endocrinol Metab., 96, 2756, 10.1210/jc.2011-0112 · DOI
  59. Patterson, 2014, Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the Childhood Cancer Survivor study, J Clin Endocrinol Metab., 99, 2030, 10.1210/jc.2013-4159 · DOI
  60. Sklar, 2002, Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor study, J Clin Endocrinol Metab., 87, 3136, 10.1210/jcem.87.7.8606 · DOI · Paper page
  61. Woodmansee, 2013, Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS, Eur J Endocrinol., 168, 565, 10.1530/EJE-12-0967 · DOI
  62. Corrias, 1997, Growth hormone treatment in irradiated children with brain tumors, J Pediatr Endocrinol Metab., 10, 41, 10.1515/JPEM.1997.10.1.41 · DOI
  63. Ogilvy-Stuart, 1992, Growth hormone and tumour recurrence, BMJ., 304, 1601, 10.1136/bmj.304.6842.1601 · DOI
  64. Packer, 2001, Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control, J Clin Oncol., 19, 480, 10.1200/JCO.2001.19.2.480 · DOI
  65. Swerdlow, 2000, Growth hormone treatment of children with brain tumors and risk of tumor recurrence, J Clin Endocrinol Metab., 85, 4444
  66. Growth Hormone Research Society., 2000, Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society, J Clin Endocrinol Metab, 85, 3990
  67. Allen, 2016, GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults, Eur J Endocrinol., 174, P1, 10.1530/EJE-15-0873 · DOI
  68. Grimberg, 2016, Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency, Horm Res Paediatr., 86, 361, 10.1159/000452150 · DOI · Paper page
  69. Ho, 2007, Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia, Eur J Endocrinol., 157, 695, 10.1530/EJE-07-0631 · DOI · Paper page
  70. Matthews, 2017, Hormone supplementation for pubertal induction in girls, Arch Dis Child., 102, 975, 10.1136/archdischild-2016-311372 · DOI
  71. Carel, 2009, Consensus statement on the use of gonadotropin-releasing hormone analogs in children, Pediatrics., 123, e752, 10.1542/peds.2008-1783 · DOI · Paper page
  72. Tamhane, 2018, GH therapy in childhood cancer survivors: a systematic review and meta-analysis, J Clin Endocrinol Metab., 103, 2794, 10.1210/jc.2018-01205 · DOI
  73. Chemaitilly, 2016, Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long-term outcomes, Clin Endocrinol (Oxf)., 84, 361, 10.1111/cen.12964 · DOI
  74. Trivin, 2006, Presentation and evolution of organic central precocious puberty according to the type of CNS lesion, Clin Endocrinol (Oxf)., 65, 239, 10.1111/j.1365-2265.2006.02582.x · DOI
  75. Molitch, 2006, Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab., 91, 1621, 10.1210/jc.2005-2227 · DOI · Paper page
  76. Junnila, 2015, Pitfalls of insulin-like growth factor-I and growth hormone assays, Endocrinol Metab Clin North Am., 44, 27, 10.1016/j.ecl.2014.10.003 · DOI
  77. El-Farhan, 2017, Measuring cortisol in serum, urine and saliva—are our assays good enough?, Ann Clin Biochem., 54, 308, 10.1177/0004563216687335 · DOI · Paper page
  78. van Iersel, 2019, Clinical importance of free thyroxine concentration decline after radiotherapy for pediatric and adolescent brain tumors, J Clin Endocrinol Metab., 104, 4998, 10.1210/jc.2019-00539 · DOI · Paper page
  79. Joshi, 2016, Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review, Clin Endocrinol (Oxf)., 85, 331, 10.1111/cen.13063 · DOI
  80. Merchant, 2002, Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function, Int J Radiat Oncol Biol Phys., 54, 45, 10.1016/S0360-3016(02)02888-2 · DOI
  81. Chemaitilly, 2016, Hypothalamic-pituitary axis dysfunction in survivors of childhood CNS tumors: importance of systematic follow-up and early endocrine consultation, J Clin Oncol., 34, 4315, 10.1200/JCO.2016.70.1847 · DOI

Cited by

Metadata

Authors
van Iersel, L., Mulder, R. L., Denzer, C., Cohen, L. E., Spoudeas, H. A., Meacham, L. R., Sugden, E., Schouten-van Meeteren, A. Y. N., Hoving, E. W., Packer, R. J., Armstrong, G. T., Mostoufi-Moab, S., Stades, A. M., van Vuurden, D., Janssens, G. O., Thomas-Teinturier, C., Murray, R. D., Di Iorgi, N., Neggers, S. J. C. M. M., Thompson, J., Toogood, A. A., Gleeson, H., Follin, C., Bardi, E., Torno, L., Patterson, B., Morsellino, V., Sommer, G., Clement, S. C., Srivastava, D., Kiserud, C. E., Fernandez, A., Scheinemann, K., Raman, S., Yuen, K. C. J., Wallace, W. H., Constine, L. S., Skinner, R., Hudson, M. M., Kremer, L. C. M., Chemaitilly, W., & van Santen, H. M.
Affiliations
  • Department of Pediatric Endocrinology, Wilhelmina Children’s Hospital, University Medical Center Utrecht , Utrecht , The Netherlands
  • Princess Máxima Center for Pediatric Oncology, Department of Neuro-oncology , Utrecht , The Netherlands
  • Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics & Adolescent Medicine, Ulm University Medical Center , Ulm , Germany
  • Division of Endocrinology, Boston Children’s Hospital , Boston, MA , USA
  • The London Centre for Pediatric Endocrinology & Diabetes , London , UK
  • Emory University School of Medicine; Atlanta, GA, USA
  • Department of Clinical Oncology , Oxford , UK
  • The Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children’s National Health System , Washington, DC , USA
  • Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital , Memphis TN , USA
  • Department of Pediatrics, The Children’s Hospital of Philadelphia, The University of Pennsylvania Perelman School of Medicine , Philadelphia, PA, USA
  • Department of Endocrinology, University Medical Center Utrecht, Utrecht , The Netherlands
  • Radiation Epidemiology Group, Center for Research in Epidemiology and Population Health (CESP), Université Paris-Sud XI , Villejuif , France
  • Department of Endocrinology, Leeds Centre for Diabetes & Endocrinology, Leeds Teaching Hospitals NHS Trust , Leeds , UK
  • Department of Pediatrics, Istituto Giannina Gaslini, University of Genova , Genova , Italy
  • Department of Internal Medicine, Endocrinology Section, Pituitary Center Rotterdam, Erasmus University Medical Center , Rotterdam , The Netherlands
  • Division of Hematology/Oncology/BMT, Children’s Mercy Hospitals and Clinics , Kansas City, Missouri , USA
  • Department of Endocrinology, Queen Elizabeth Hospital Birmingham , Birmingham , UK
  • Department of Oncology, Skåne University Hospital , Lund , Sweden
  • Department of Pediatrics and Adolescent Medicine, Kepler Universitätsklinikum , Linz , Austria
  • Division of Pediatric Oncology, CHOC Children’s Hospital/University of California , Orange, CA , USA
  • DOPO Clinic, Division of Pediatric Hematology/Oncology, IRCCS Istituto Giannina Gaslini , Genova , Italy
  • Swiss Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern , Bern , Switzerland
  • Department of Pediatrics, Amsterdam University Medical Center, location VU University Medical Center , Amsterdam , The Netherlands
  • Department of Biostatistics, St. Jude Children’s Research Hospital , Memphis TN , USA
  • Department of Oncology, National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital , Oslo , Norway
  • Endocrinology Department, Hospital Universitario de Mostoles , Madrid , Spain
  • Division of Pediatric Hematology/Oncology, Department of Pediatrics, Kantonsspital Aarau , Aarau , Switzerland
  • Division of Pediatric Endocrinology and Diabetes, Children’s Hospital of Pittsburgh , Pittsburgh, PA, USA
  • Department of Neuroendocrinology and Neurosurgery, Barrow Pituitary Center, Barrow Neurological Institute, University of Arizona College of Medicine , Phoenix, AZ , USA
  • Department of Paediatric Oncology, Royal Hospital for Sick Children , Edinburgh , UK
  • Departments of Radiation Oncology and Pediatrics, University of Rochester Medical Center , Rochester, NY , USA
  • Department of Paediatric and Adolescent Haematology/Oncology, Great North Children’s Hospital and Newcastle University Centre for Cancer , Newcastle upon Tyne , UK
  • Department of Epidemiology and Cancer Control, and Oncology, St. Jude Children’s Research Hospital , Memphis, TN , USA
  • Division of Endocrinology and Epidemiology and Cancer Control, St. Jude Children’s Research Hospital , Memphis, TN , USA
ORCID
Venue
Endocrine Reviews
Publisher
The Endocrine Society
Published
2021-11-20
Volume
43
Issue
5
Pages
794-823
ISSN
  • 0163-769X
  • 1945-7189
DOI
10.1210/endrev/bnab040
Cited by
66
References
12
Language
en
Licence
academic.oup.com/pages/standard-publication-reuse-rights (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.